KalVista Pharmaceuticals (KALV) Stock Chart & Stock Price History $13.88 +0.50 (+3.74%) Closing price 09/18/2025 04:00 PM EasternExtended Trading$14.25 +0.37 (+2.67%) As of 08:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KalVista Pharmaceuticals Stock Price Performance The KalVista Pharmaceuticals (KALV) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 26.18%, with a year-to-date return of 63.87%. In the past month, the stock has increased 8.35%, reflecting recent market activity. As of the latest close, KalVista Pharmaceuticals traded at $13.88 with a market cap of $676.00 million and volume of 561,114 shares. Five years ago, the stock traded at $13.79, representing a 0.65% increase over that period. At the time, it had a market cap of $246.95 million and a volume of 62,911 shares. Receive KALV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.93%1 Month Performance+8.35%3 Month Performance+12.75%Year-To-Date Performance+63.87%1 Year Performance+26.18%5 Year Performance+0.65% KALV Stock Chart for Friday, September, 19, 2025 KALV Chart by TradingView KalVista Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/18/2025$13.38$13.88+3.74%$13.91$13.41561,114 shs$676.00 million09/17/2025$13.50$13.38-0.89%$13.93$13.35536,478 shs$675.96 million09/16/2025$13.62$13.50-0.88%$14.25$13.47871,431 shs$682.02 million09/15/2025$14.01$13.62-2.78%$14.14$13.50826,600 shs$685.63 million09/12/2025$14.81$14.01-5.40%$14.89$13.442.23 million shs$705.26 million09/11/2025$15.39$14.81-3.77%$17.28$13.262.89 million shs$745.54 million09/10/2025$15.61$15.39-1.41%$15.78$15.21858,951 shs$774.73 million09/09/2025$15.96$15.61-2.19%$16.14$15.361.09 million shs$785.81 million09/08/2025$15.82$15.96+0.88%$16.33$15.651.34 million shs$803.43 million09/05/2025$15.20$15.82+4.08%$15.85$15.041.08 million shs$796.38 million Get the Latest News and Ratings for KALV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/04/2025$14.16$15.20+7.34%$15.30$13.721.32 million shs$765.17 million09/03/2025$14.29$14.16-0.91%$14.78$14.141.42 million shs$712.81 million09/02/2025$13.46$14.29+6.17%$14.30$13.471.14 million shs$719.36 million09/01/2025$13.46$13.46$13.78$13.23436,472 shs$677.58 million08/29/2025$13.51$13.46-0.37%$13.78$13.23436,472 shs$677.58 million08/28/2025$13.59$13.51-0.59%$13.96$13.38416,522 shs$680.09 million08/27/2025$13.16$13.59+3.27%$13.62$13.12342,039 shs$684.12 million08/26/2025$12.99$13.16+1.31%$13.20$12.90886,087 shs$662.47 million08/25/2025$13.41$12.99-3.13%$13.65$12.98543,269 shs$648.90 million08/22/2025$12.96$13.41+3.47%$13.53$12.87590,122 shs$669.88 million08/21/2025$12.91$12.96+0.39%$13.04$12.68396,887 shs$647.35 million08/20/2025$12.81$12.91+0.78%$12.98$12.30577,137 shs$644.85 million08/19/2025$13.34$12.81-3.97%$13.38$12.66595,438 shs$639.91 million08/18/2025$12.88$13.34+3.57%$13.52$12.811.00 million shs$666.33 million Related Companies IMVT Stock Price Chart XENE Stock Price Chart VKTX Stock Price Chart OGN Stock Price Chart KNSA Stock Price Chart NAMS Stock Price Chart BHC Stock Price Chart GMTX Stock Price Chart CGON Stock Price Chart MLYS Stock Price Chart Receive KALV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KALV) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KalVista Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KalVista Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
